This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • most patients have a chronic intermittent disease course, while 13% have an unremitting disease course and 10% have a prolonged remission
  • less than half require corticosteroids at any point
  • during any given year, approximately 10% are treated with corticosteroids and 30% are treated with 5-aminosalicylates
  • up to 57% of patients require at least one surgical resection
  • about one tenth of patients have prolonged remission (1)
  • nearly 75% of patients have a chronic intermittent course, and about one eighth have an unremitting course
  • if the patient has both small and large bowel disease then about 70% will require surgical intervention.

The atypical form of Crohn's is an acute ileitis. This, unlike other forms of Crohn's, does not recur and may represent a completely different disease.

The excess mortality in patients with Crohn's disease is approximately double that of the general population. This is due to the complications of active disease.

Reference:

  1. Aliment Pharmacol Ther 2002 Jan;16(1):51-60

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.